See CSO Tom Turi at the Spatial Biology for Drug Development Summit.
Partner with us for leading edge genomics capabilities, including NGS with our new NovaSeq™ X Plus.
We have been recognized with a Frost & Sullivan 2023 Customer Value Leadership Award.
Bringing innovative approaches to your clinical development program
Flagship Biosciences is a leader in supporting drug development through biomarker analytics and the application of spatial biology technologies
We are your source for spatial biology expertise, moving your research forward every step of the way. Our mission is to explore complex biomarkers within the context of disease in order to advance your precision medicine strategy.
We embrace innovative, breakthrough technologies and have developed the deep technical expertise to harness them effectively. Our team can assist with platform selection, assay design and optimization, validation and deployment of complex multi-analyte assays combined with image and data analysis in support of your drug development objectives.
Biomarker Solutions
We provide a comprehensive biomarker solutions service that encompasses broad testing capabilities. Our team of experts is equipped to handle a wide range of biomarker analysis needs, ranging from basic research to clinical diagnosis and drug development. We utilize cutting-edge technology and state-of-the-art methodologies to provide accurate and reliable results that can inform clinical decisions and support drug development programs. Whether you require assistance with single biomarker analysis or multiplex assays, we can offer the support you need to achieve your goals. You can trust Flagship Biosciences to deliver the highest quality biomarker solutions and support for your research needs.
Our assay development service is designed to provide tailored solutions that meet your specific research needs. Our team of experts is dedicated to developing assays that deliver accurate and reliable results, and we use advanced techniques and state-of-the-art technology to ensure that our assays are of the highest quality. We start with the end in mind, tailoring our assays to the right targets in the right patients on the right platforms. Our expertise in assay development enables us to provide valuable insights that can inform clinical decisions and support drug development programs.
See CSO Tom Turi at the Spatial Biology for Drug Development Summit.
Partner with us for leading edge genomics capabilities, including NGS with our new NovaSeq™ X Plus.
We have been recognized with a Frost & Sullivan 2023 Customer Value Leadership Award.
Biomarker Solutions
We provide a comprehensive biomarker solutions service that encompasses broad testing capabilities. Our team of experts is equipped to handle a wide range of biomarker analysis needs, ranging from basic research to clinical diagnosis and drug development. We utilize cutting-edge technology and state-of-the-art methodologies to provide accurate and reliable results that can inform clinical decisions and support drug development programs. Whether you require assistance with single biomarker analysis or multiplex assays, we can offer the support you need to achieve your goals. You can trust Flagship Biosciences to deliver the highest quality biomarker solutions and support for your research needs.
Our assay development service is designed to provide tailored solutions that meet your specific research needs. Our team of experts is dedicated to developing assays that deliver accurate and reliable results, and we use advanced techniques and state-of-the-art technology to ensure that our assays are of the highest quality. We start with the end in mind, tailoring our assays to the right targets in the right patients on the right platforms. Our expertise in assay development enables us to provide valuable insights that can inform clinical decisions and support drug development programs.
Spatial Biology Expertise
Cells do not function in isolation but are strongly influenced by their spatial location and surroundings. Collaborating with a proficient partner having specialized knowledge in extracting and analyzing such contextual information can prove crucial in ensuring successful implementation of your development program. Flagship Biosciences has the medical, analytical, and data science expertise to help you achieve your goals.
Flagship Biosciences operates CLIA-certified and CAP-accredited laboratories that employ highly experienced, board-certified pathologists. These proficient experts oversee all stages of your project, utilizing our state-of-the-art multi-omics and cell-biology technologies.
Multiplex IHC and In Situ Hybridization are powerful diagnostic tools that enable the simultaneous detection of multiple biomarkers in a single sample. Flagship Biosciences offers a comprehensive service that includes the development, validation, and execution of multiplex IHC, FISH, and CISH assays that can detect up to six biomarkers per sample. Our state-of-the-art technology and expertise in the field enable us to provide accurate and reliable results that can help inform clinical decisions and support drug development programs. With Flagship Biosciences, you can trust that your multiplex assays are in the hands of experienced professionals who are dedicated to delivering the highest quality service possible.
Flagship provides a range of genomic analysis services that encompass various techniques and applications. Our team of experts is well-equipped and proficient in handling diverse forms of genomic analysis, including full genome sequencing, RNA sequencing, spatial transcriptomics, and methylation sequencing. We utilize state-of-the-art technologies and advanced methods to ensure that our results are accurate and reliable. Furthermore, our molecular extraction capabilities are robust, allowing us to work with a diverse range of sample types and formats. Whether you are engaged in basic research or drug development, our genomics services offer valuable insights to help you achieve your goals. You can trust Flagship Biosciences to offer the highest quality results and support for all your genomic analysis needs.
Our scientific and medical teams are experienced in flow cytometry assessments supporting many applications including hematopoietic neoplasms, MRD, receptor occupancy, expansive immunophenotyping, and Immuno-oncology assessments.
Flagship Biosciences has developed a state-of-the-art digital pathology and image analysis department that is staffed by a team of highly skilled professionals. Our experts utilize our proprietary artificial intelligence software, Flotilla, to create customized deep-learning solutions that cater to your target disease states and biomarkers.
Our capable data science group specializes in sophisticated multi-omic projects. We possess the expertise required to seamlessly integrate disparate data sets into holistic conclusions that offer valuable insights for your research project. We utilize advanced methodologies and cutting-edge technology to deliver the comprehensive and accurate answers your program requires.